Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Aug 2018 16:49

RNS Number : 8019X
Motif Bio PLC
14 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Motif Bio plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Prudential plc group of companies

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

13/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

14/08/2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.11%

0.00%

5.11%

296,660,243

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

ORD GBP0.01

GB00BVVT4H71

15,177,151

5.11%

SUBTOTAL 8. A

15,177,151

5.11%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Prudential plc

(Parent Company)

 

5.11%

0.00%

5.11%

M&G Group Limited

(wholly owned subsidiary of Prudential plc)

5.11%

0.00%

5.11%

M&G Limited

(wholly owned subsidiary of M&G Group Limited)

5.11%

0.00%

5.11%

M&G Investment

Management Limited

(wholly owned subsidiary of M&G Limited)

5.11%

0.00%

5.11%

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

London, United Kingdom

Date of completion

14 August 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLLLFSETTISLIT
Date   Source Headline
17th Apr 20187:00 amRNSPosting of UK Annual Report and Notice of AGM
11th Apr 20182:30 pmRNSIclaprim Abstracts for ECCMID 2018 Now Online
10th Apr 20187:00 amRNSFiscal Year 2017 Results
3rd Apr 20183:29 pmRNSHolding(s) in Company
3rd Apr 20187:00 amRNSInitiation of NDA Rolling Submission for Iclaprim
20th Mar 20187:00 amRNSMotif Bio Update on NDA Submission for Iclaprim
19th Mar 20187:00 amRNSMotif Bio to present at upcoming conferences
13th Mar 20183:55 pmRNSChange of Registered Office
7th Mar 201812:29 pmRNSExercise of Warrants
1st Mar 20187:00 amRNSGrant of share options to senior management
21st Feb 20187:00 amRNSMotif Bio to Present Iclaprim Data at ECCMID 2018
19th Feb 201812:53 pmRNSExercise of Warrants
2nd Feb 20183:00 pmRNSAppointment of Interim Chief Financial Officer
29th Jan 201812:07 pmRNSSecond Price Monitoring Extn
29th Jan 201812:02 pmRNSPrice Monitoring Extension
19th Jan 20187:00 amRNSFiling of U.S. Shelf Registration
16th Jan 20187:00 amRNSMotif Bio Receives Award from CF Foundation
12th Jan 20183:12 pmRNSHolding(s) in Company
11th Jan 20183:07 pmRNSHolding(s) in Company
8th Jan 20183:23 pmRNSExercise of Warrants
5th Jan 20187:00 amRNSMotif Bio to participate in panel discussion
22nd Dec 20177:01 amRNSNotes statement from Amphion Innovations
21st Dec 20171:00 pmRNSREVIVE-1 additional results published
14th Dec 20177:00 amRNSFiling of SEC Form F-3
28th Nov 20176:24 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSExercise of Warrants
17th Nov 20177:00 amRNSHolding(s) in Company
15th Nov 20177:00 amRNSSecures up to US$20 million debt financing
9th Nov 20172:40 pmRNSExercise of Warrants
6th Nov 201712:29 pmRNSHolding(s) in Company
18th Oct 20177:00 amRNSHolding(s) in Company
6th Oct 20171:20 pmRNSHolding(s) in Company
6th Oct 20177:00 amRNSNew Pre-Clinical Data for Iclaprim at IDWeek 2017
5th Oct 20179:57 amRNSHolding(s) in Company
4th Oct 20177:00 amRNSPositive Topline Results in Phase Three Study
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:01 amRNSHolding(s) in Company
15th Sep 20172:07 pmRNSiclaprim granted Orphan Drug Designation by US FDA
8th Sep 20171:00 pmRNSHost Investor and Analyst Event on September 20
31st Aug 20171:00 pmRNSCompany to present at conferences in September
30th Aug 20177:00 amRNSHolding(s) in Company
9th Aug 20177:00 amRNSREVIVE 2 Trial Last Patient Treated
18th Jul 20177:00 amRNSAmendment to Amphion Consultancy Agreement
6th Jul 20177:00 amRNSPRESENTING THREE POSTERS ON ICLAPRIM AT ID WEEK
28th Jun 201712:41 pmRNSExercise of warrants
27th Jun 20177:00 amRNSHolding(s) in Company
22nd Jun 20173:20 pmRNSResult of General Meeting
22nd Jun 20177:00 amRNSPresents at ID Week 2017
15th Jun 20175:42 pmRNSResults of Annual General Meeting
14th Jun 20177:00 amRNSPresentation at BIO International Convention

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.